Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001670254-23-001061
Filing Date
2023-11-20
Accepted
2023-11-20 15:59:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 11665
2 document_1.pdf EX-99 8151181
3 document_2.pdf EX-99 6268417
4 document_3.pdf EX-99 12685257
5 document_4.pdf EX-99 19654186
6 document_5.pdf EX-99 19651865
7 document_6.pdf EX-99 12685535
8 document_7.pdf EX-99 11155473
9 document_8.pdf EX-99 489384
10 document_9.pdf EX-99 5093177
11 documents_list.htm EX-99 123
  Complete submission text file 0001670254-23-001061.txt   129589373
Mailing Address 223 WALL STREET, #130 HUNTINGTON NY 11743
Business Address 223 WALL STREET, #130 HUNTINGTON NY 11743 201-400-8083
SEN-JAM PHARMACEUTICAL INC. (Filer) CIK: 0001802249 (see all company filings)

EIN.: 822750291 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-32408 | Film No.: 231422680